Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Methylene Blue in Septic Shock (BLUSH)
NCT06900140Phase 3Completed
- Start
- Jun 2025
- Primary completion
- Mar 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of methylene blue in septic shock. Started Jun 2025; status: completed.
02
Drugs
methylene blue
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT06900140.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06900140.